Anondita Medicare IPO Details
Here is a detailed overview of the Anondita Medicare IPO for 2025:
Company Overview
Anondita Medicare Limited, incorporated in 1990, is a manufacturer and marketer of sexual wellness products. Its flagship brand, “COBRA,” is a well-recognized condom brand in India. The company operates a large-scale manufacturing facility with an installed capacity of 562 million condoms annually. It emphasizes quality and safety and caters to both the Indian domestic market and international exports.
IPO Key Details
Detail | Information |
---|---|
IPO Opening Date | August 22, 2025 |
IPO Closing Date | August 26, 2025 |
Allotment Date | August 28, 2025 |
Refund Initiation Date | August 29, 2025 |
Share Credit to Demat | August 29, 2025 |
Listing Date | September 1, 2025 |
Exchange Listing | NSE (SME Platform) |
Face Value | ₹10 per share |
Price Band | ₹137 to ₹145 per share |
Minimum Lot Size | 1000 shares |
Minimum Retail Investment | 2 lots (2000 shares), approx ₹2,74,000 |
IPO Size | ₹69.50 Crores |
Number of Shares on Offer | 47,93,000 equity shares (fresh issue only) |
Type of Issue | 100% Fresh Issue (no Offer For Sale) |
Registrar | Maashitla Securities Private Limited |
Book Running Lead Manager | Narnolia Financial Services Limited |
Market Maker | Mansi Share & Stock Broking Pvt Ltd |
Objectives of the IPO Capital
To meet general corporate purposes.
To fund working capital requirements.
To finance capital expenditure, including equipment purchase.
Investment and Application Details
Retail investors must apply for a minimum of 2 lots (2000 shares), with an investment around ₹2,74,000.
High Net Worth Individuals (HNI) need to apply for at least 3 lots (3000 shares) requiring an investment of approximately ₹4,35,000.
The IPO is being issued through the book-building method.
Investors can apply through ASBA (Application Supported by Blocked Amount) or UPI-based methods via banks or registered brokers.
Market and Valuation Insights
Grey Market Premium (GMP) around ₹65 as of August 22, 2025, suggesting an estimated listing price of ₹210 per share.
This translates to an estimated listing gain of about 44.83%.
The issue size is ₹69.5 crore entirely through fresh equity issue, with no shares being sold by current promoters or investors.
Company Strength and Business Model
Leading player in the condom manufacturing segment under the “COBRA” brand.
Strong manufacturing capability with modern quality control systems.
Expanding distribution across India and growing export markets.
Committed workforce and certifications to comply with international quality standards.
Positioned in the healthcare and personal care sector, with growing demand for sexual wellness products.
Anchor Investors
Five anchor investors have been allotted shares before the public issue, including Vikasa India EIF, Sageone - Flagship, Cognizant Capital Dynamic, Minerva Emerging Opportunities, and Pine OAK Global.
IPO Timeline Summary
Event | Date |
---|---|
IPO Open | August 22, 2025 |
IPO Close | August 26, 2025 |
Allotment Finalization | August 28, 2025 |
Refund Initiation | August 29, 2025 |
Share Credit to Demat | August 29, 2025 |
Listing on NSE SME | September 1, 2025 |
Contact and Support
Registrar: Maashitla Securities Private Limited (for allotment queries and refunds)
Lead Manager: Narnolia Financial Services Limited (handling underwriting and IPO processes)
Market Maker: Mansi Share & Stock Broking Pvt. Ltd.
This comprehensive outline of the Anondita Medicare IPO covers its background, issue size, subscription details, objectives, timeline, and market expectations. Investors should consider the IPO price band, the lot size investment requirements, and the business fundamentals before applying. The issue is poised to list on September 1, 2025, on NSE SME, with an anticipated strong market debut based on GMP and investor interest
Follow Me
Comments
Post a Comment